Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
Arq Gastroenterol ; 19(1): 17-21, 1982.
Artículo en Portugués | MEDLINE | ID: mdl-6295348

RESUMEN

Ten subjects were studied for two periods of six days each during which they were fed respectively a regular diet (control diet) followed by a fiber-supplemented diet (experimental diet). The experimental diet consisted of a regular diet in which some foods where substracted and some bran biscuits, specially produced for this investigation, were added. The experimental diet produced a significant increase in daily stool weight, dried stool weight, water contents of the stools and intestinal transit time. The study has shown that special bran biscuits is effective in promoting a increase in bowel transit time, and therefore should be submitted to therapeutic trial in patients with constipation.


Asunto(s)
Fibras de la Dieta/administración & dosificación , Heces , Adulto , Estreñimiento/dietoterapia , Estreñimiento/fisiopatología , Heces/análisis , Femenino , Motilidad Gastrointestinal , Humanos , Masculino , Persona de Mediana Edad , Nitrógeno/metabolismo , Agua/metabolismo
2.
Arq Gastroenterol ; 20(1): 3-7, 1983.
Artículo en Portugués | MEDLINE | ID: mdl-6625954

RESUMEN

Ten patients with uncomplicated duodenal ulcer were given three different therapeutic regimens of antacid experiments II, III and IV, and a control regimen, without antacid, named experiment I. Experiment I consisted of a normal diet with three meals a day; experiment II, III and IV consisted of a diet as in experiment I plus 132,06 mEq, 265,92 mEq or 396,88 mEq respectively of antacid divided in six equal doses given one and three hours after breakfast, lunch and dinner. Having been carefully instructed, the patients were intubated with a gastric tube, which was kept in for five days, receiving in each day one of the aforementioned regimens, in a sequential order. The fifth day was reserved for the augmented Histalog test. Each hour from 8 a.m. to 10 p.m., in the first four days, a sample of the gastric juice was aspirated for pH measurement. The statistical evaluation of the acidity of the samples at different times showed that experiment III (265,92 mEq antacid/day) was able to keep the pH over 3 for longer periods of time when compared with experiments I and II and not different from experiment IV. The present investigation emphasize the necessity of clinical trials comparing therapeutic regimens of antacid with different neutralizing capacity, in order to find the most effective dose in the treatment of duodenal ulcer.


Asunto(s)
Antiácidos/administración & dosificación , Úlcera Duodenal/tratamiento farmacológico , Determinación de la Acidez Gástrica , Adulto , Dieta , Esquema de Medicación , Ácido Gástrico/metabolismo , Humanos , Masculino , Persona de Mediana Edad
3.
Arq Gastroenterol ; 20(3): 85-91, 1983.
Artículo en Portugués | MEDLINE | ID: mdl-6677255

RESUMEN

A prospective study of the effects of maximal doses of betazol hydrochloride ( Histalog ) on the endoscopic and histologic findings of the gastric mucosa of volunteers was made. Of the 11 patients examined, no alteration was seen on gastroscopic examination after Histalog in three, slight to moderate congestion of the mucosa in six and scattered oozing bleeding points in two. The study of the histologic findings revealed no statistical significant difference in the recurrence of erosion, hemorrhage and edema in the antrum and body gastric mucosa, before and after the administration of Histalog . It was concluded that maximal doses of Histalog cause no significant hemorrhage in the mucosa of the stomach and that the brown colour frequently seen in the gastric secretions of the final portions of a Histalog test is to be attributed to trauma to the mucosa by the nasogastric tube and to Histalog induced congestion of the mucosa.


Asunto(s)
Betazol , Ácido Gástrico/metabolismo , Mucosa Gástrica/patología , Pirazoles , Adolescente , Adulto , Betazol/farmacología , Biopsia con Aguja , Femenino , Mucosa Gástrica/efectos de los fármacos , Gastroscopía , Humanos , Masculino , Persona de Mediana Edad
4.
Arq Gastroenterol ; 21(3): 113-5, 1984.
Artículo en Portugués | MEDLINE | ID: mdl-6100041

RESUMEN

In eight fasting men with duodenal ulcer disease, oral administration of therapeutic dose of 49,5 mEq of neutralizing potency of either sodium bicarbonate or a preparation of calcium hidroxogluconaluminate did not produce significant increase in gastric acid secretion above basal levels for 90 minutes. This data support the conclusion that this specific antacid-containing calcium preparation does not stimulate the gastric secretion of acid.


Asunto(s)
Antiácidos/farmacología , Bicarbonatos/farmacología , Calcio/farmacología , Úlcera Duodenal/metabolismo , Ácido Gástrico/metabolismo , Humanos , Bicarbonato de Sodio
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda